×

Levothyroxine compositions having unique triiodothyronine Cmax properties

  • US 20030194437A1
  • Filed: 08/14/2002
  • Published: 10/16/2003
  • Est. Priority Date: 08/14/2001
  • Status: Abandoned Application
First Claim
Patent Images

1. An immediate release pharmaceutical composition comprising a levothyroxine salt, wherein the composition exhibits a triiodothyronine (T3) plasma Cmax of between from about 0.1 ng/ml to about 10 ng/ml as determined by the standard Cmax test.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×